PHARMACEUTICAL PREPARATIONS TREATING CYSTINOSIS

Brand Owner (click to sort) Address Description
AKISTRELA RAPTOR PHARMACEUTICALS INC. Suite 100 7 Hamilton Landing Novato CA 94949 Pharmaceutical preparations for treating cystinosis and nephropathic cystinosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating kidney disorders; pharmaceutical preparations for treating liver diseases and disorders; sustained release cysteamine;
BICYSBI RAPTOR PHARMACEUTICALS INC. Suite 100 7 Hamilton Landing Novato CA 94949 Pharmaceutical preparations for treating cystinosis and nephropathic cystinosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating kidney disorders; pharmaceutical preparations for treating liver diseases and disorders; sustained release cysteamine;
BIOCYSBI RAPTOR PHARMACEUTICALS INC. Suite 100 7 Hamilton Landing Novato CA 94949 Pharmaceutical preparations for treating cystinosis and nephropathic cystinosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating kidney disorders; pharmaceutical preparations for treating liver diseases and disorders; sustained release cysteamine;
BYCYSBI RAPTOR PHARMACEUTICALS INC. Suite 100 7 Hamilton Landing Novato CA 94949 Pharmaceutical preparations for treating cystinosis and nephropathic cystinosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating kidney disorders; pharmaceutical preparations for treating liver diseases and disorders; sustained release cysteamine;
CYSBI RAPTOR THERAPEUTICS INC. 9 COMMERCIAL BOULEVARD NOVATO CA 94949 Pharmaceutical preparations for treating cystinosis and nephropathic cystinosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating kidney disorders; pharmaceutical preparations for treating liver diseases and disorders; sustained release cysteamine;
KESTRELA RAPTOR THERAPEUTICS INC. 9 COMMERCIAL BOULEVARD NOVATO CA 94949 Pharmaceutical preparations for treating cystinosis and nephropathic cystinosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating kidney disorders; pharmaceutical preparations for treating liver diseases and disorders; sustained release cysteamine;
RAPTOR RAPTOR PHARMACEUTICALS INC. Suite 100 7 Hamilton Landing Novato CA 94949 Pharmaceutical preparations for treating cystinosis and nephropathic cystinosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating kidney disorders; pharmaceutical preparations for treating liver diseases and disorders; sustained release cysteamine;
RAPTOR PHARMACEUTICAL CORP. Raptor Pharmaceutical Corp. Suite 160 5 Hamilton Landing Novato CA 94949 Pharmaceutical preparations for treating cystinosis and nephropathic cystinosis; pharmaceutical preparations for treating neurological diseases and disorders; pharmaceutical preparations for treating kidney disorders; pharmaceutical preparations for treating liver diseases and disorders; sustained release cysteamine;PHARMACEUTICAL CORP.;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.